MannKind Corporation to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

   PDF    Add to Briefcase

VALENCIA, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 3:30 PM (ET) at the Le Parker Meridien in New York. 

Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer. 

Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation  

MannKind Corporation (Nasdaq and TASE: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price: 0.50

Change: 0.01 (2.245%)

Volume: 9,246,897

Data as of
02/23/2017 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

Locations

Learn more about MannKind's offices in the United States

Learn More